Professional Documents
Culture Documents
Clinical Nutrition
Chapter 21
Parenteral Nutrition
1.
2.
3.
4.
5.
Costly
Liver dysfunction
Progressive kidney problems
Bone disorders
Many nutrient deficiencies
Parenteral Nutrients
Amino acids
3.5 15%
4 kcalories per gram
A 10% amino acid solution 10 grams amino
acids per 100 mL
Disease specific solutions for patients with:
liver disease, kidney failure and metabolic
stress
Parenteral Nutrients
Carbohydrate
2.5 70%
3.4 kcalories per gram
Concentrations > 10% - administered through
central lines
Parenteral Nutrients
Lipids
Often contain triglycerides from soybean oil
and safflower oil, phospholipids
Lipid emulsions available in 10, 20, 30%
solutions
Often provided daily
May provide 20-30% of total kcalories
Parenteral Nutrients
Lipids
As an energy source, reduces the need for
energy from dextrose.
Lowers the risk of hyperglycemia in glucoseintolerant patients.
Need to be restricted in patients with
hypertriglyceridemia.
Concern about excessive linoleic content may
suppress immune response.
Parenteral Nutrients
Fluids and electrolytes
3040 mL/kg - daily young adults
30 mL/kg daily older adults
Sodium, potassium, chloride, calcium,
magnesium, and phosphorus
Daily lab tests to monitor electrolyte status
Parenteral Nutrients
Vitamins and trace minerals
Multivitamin and trace minerals added
Vitamin K often omitted added separately
Iron excluded alters stability of other
ingredients given by injection
Parenteral Nutrients
Osmolarity
PPN 900 milliosmoles / liter
TPN as nutrient dense as necessary
Amino acids, dextrose and electrolytes
contribute most to the osmolarity
Medications
May be added directly or by piggyback insulin,
heparin
Formula Preparation
Depends on patients:
Medical condition
Nutritional status
PPN or TPN
Formula Preparation
2-in-one solution
Dextrose, amino acids
Administering
Parenteral
Nutrition
Nutrition
support
team
Administration of Parenteral
Solutions
Start at a slow rate
Gradually increase over a two- to three
day period
1 liter on first day
Increase by one liter per day until goal
reached
Administration of Parenteral
Solutions
May begin full volume of diluted solution
on first day
Chance of hypoglycemia
Managing Metabolic
Complications
Hyperglycemia
Occurs in patients who are glucose-intolerant
Occurs in in patients who are undergoing
stress
Prevented by providing insulin
Limiting dextrose content of solutions
Premature infants at risk pancreas and liver
not fully functioning
Managing Metabolic
Complications
Hypoglycemia
Occurs when feedings are interrupted or
discontinued
Young infants at risk taper feedings off
over several hours
Managing Metabolic
Complications
Hypertriglyceridemia
May occur in critically ill patients
May result from excessive carbohydrate
feedings or severe infection
If blood triglyceride levels exceed 350 to 400
milligrams/deciliter lipid infusion is reduced or
stopped
Managing Metabolic
Complications
Refeeding syndrome
Occurs when severely malnourished patients are fed
aggressively
Characterized by electrolyte and fluid imbalances and
hyperglycemia
Promotes anabolic processes that quickly remove
phosphate, potassium and magnesium
Leads to fluid retention and changes in organ systems
Managing Metabolic
Complications
Abnormalities in liver function
Fatty liver often results
Monitor serum levels of liver enzymes
Usually readily reversed when parenteral feedings
discontinued
May become chronic irreversible liver disease when
parenteral nutrition is continued long-term - lead to
liver failure
10
Managing Metabolic
Complications
Gallbladder disease
Sludge often builds up in gallbladder if
parenteral nutrition >4 weeks
May eventually lead to gallstones
May be given chlecystokinin injections or
have gallbladder removed surgically
Managing Metabolic
Complications
Metabolic bone disease
Decrease bone density and mineralization
May alter calcium, phosphorus, and Vitamin D
metabolism
May alter function of parathyroid gland
causing disruptions in bone metabolism
Discontinuing intravenous
feedings
Transitional feedings
Taper off parenteral feedings as tube feedings
or oral feedings are begun
Small enteral feedings given at first to assess
tolerance
If nausea, vomiting, bloating or diarrhea
develop give enteral feedings more slowly
11
Discontinuing intravenous
feedings
Transitional feedings
May use progression diet, see Chapter 18.
Patients appetite may be suppressed for
several weeks after termination of parenteral
feedings
Patients may have better appetites during the
day if they are given nocturnal cyclic feedings
before beginning oral intakes
Disturbed sleep
Social issues
Health practitioners should be ready to
recommend support groups or counseling
resources to help patients cope with ongoing
stresses.
12